Address
Johnson & Johnson Development Corp Inc
410 George Street
New Brunswick, NJ 08933
United States
Phone
Website
Recent investment activity
KANDO id: 1964
Corporate information
Official name
Johnson & Johnson Innovation LLC
Also known as
JJDC Inc
Johnson & Johnson Development Corp Inc
Registration country
Company type
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses.Relation
Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 83| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Progen Pharmaceuticals Inc | Develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. | N/A | |||
|
Replidyne Inc | Biopharmaceutical company, engages in discovering, developing, in-licensing, and commercializing anti-infective products. | N/A | |||
|
|
Rigel Pharmaceuticals Inc | N/A | ||||
|
|
Sleep Solutions Inc | N/A | ||||
|
|
Symphony Medical Inc | Series A | ||||
|
|
Torrey Pines Therapeutics Inc | N/A | ||||
|
|
TransVascular Inc | Medical device company that has developed the next-generation vascular devices. | N/A | |||
|
|
ViaCyte Inc | N/A | ||||
|
|
Vivant Medical Inc | Developer of microwave ablation technology for the minimally invasive treatment of benign and cancerous soft tissue tumors. | Series C | |||
|
23andMe Inc | DNA testing and genome sequencing firm. | Series C | |||
|
|
23andMe Inc | DNA testing and genome sequencing firm. | Series C Initial investment | |||
|
Acclarent Inc | N/A Initial investment | ||||
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series B | |||
|
|
Aclara Biosciences Inc | Develops and distributes assay solutions for drug discovery and development | N/A | |||
|
|
Acorda Therapeutics Inc | A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. | N/A | |||
|
|
Aquinox Pharmaceuticals Inc | Developer of small molecule therapeutics for the treatment of inflammatory disease | Series C | |||
|
|
Arbor Surgical Technologies Inc | Developer of a new tissue based replacement heart valve. | N/A Initial investment | |||
|
|
Biolex Therapeutics Inc | Series D | ||||
|
|
Biolex Therapeutics Inc | Series C | ||||
|
|
Biolex Therapeutics Inc | Series B | ||||
|
|
Biolex Therapeutics Inc | N/A | ||||
|
|
Breathe Technologies Inc | Developer and manufacturer of innovative therapeutic respiratory systems. | Series C | |||
|
CardioMEMS Inc | Medical device company that develops wireless medical pressure sensors. | Series C Initial investment | |||
|
|
CardioMEMS Inc | Medical device company that develops wireless medical pressure sensors. | Series B | |||
|
|
Cougar Biotechnology Inc | Acquisition |